Annual Revenue
N/A
31 December 2023
Summary:
Theriva Biologics annual revenue is not available.TOVX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
01 September 2024
Summary:
Theriva Biologics quarterly revenue is not available.TOVX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
01 September 2024
Summary:
Theriva Biologics TTM revenue is not available.TOVX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
TOVX Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
Theriva Biologics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2010 | $2.61 M(+2435.4%) | $69.20 K(-76.1%) | $2.61 M(+0.7%) |
Sept 2010 | - | $289.90 K(-86.8%) | $2.60 M(+10.1%) |
June 2010 | - | $2.19 M(+3558.2%) | $2.36 M(+1345.7%) |
Mar 2010 | - | $60.00 K(+15.4%) | $163.10 K(+58.2%) |
Dec 2009 | $103.10 K(+931.0%) | $52.00 K(+1.8%) | $103.10 K(+101.8%) |
Sept 2009 | - | $51.10 K(-31.9%) | $51.10 K(-39.9%) |
Mar 2003 | - | $75.00 K(+650.0%) | $85.00 K(+750.0%) |
Dec 2002 | $10.00 K(-98.9%) | - | - |
June 2002 | - | $10.00 K(-98.6%) | $10.00 K(-99.0%) |
Dec 2001 | $874.10 K(+72.5%) | - | - |
June 2001 | - | $693.30 K(+222.8%) | $954.20 K(+88.4%) |
Dec 2000 | $506.60 K(+26.8%) | $214.80 K(+365.9%) | $506.60 K(+3.1%) |
Sept 2000 | - | $46.10 K(-63.0%) | $491.20 K(-9.9%) |
June 2000 | - | $124.50 K(+2.7%) | $545.10 K(+11.1%) |
Mar 2000 | - | $121.20 K(-39.2%) | $490.60 K(+24.1%) |
Dec 1999 | $399.40 K(+14.1%) | $199.40 K(+99.4%) | $395.40 K(+170.8%) |
Sept 1999 | - | $100.00 K(+42.9%) | $146.00 K(0.0%) |
June 1999 | - | $70.00 K(+169.2%) | $146.00 K(-69.3%) |
Mar 1999 | - | $26.00 K(-152.0%) | $476.00 K(-13.5%) |
Dec 1998 | $350.00 K | -$50.00 K(-150.0%) | $550.00 K(-45.0%) |
Sept 1998 | - | $100.00 K(-75.0%) | $1.00 M(0.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 1998 | - | $400.00 K(+300.0%) | $1.00 M(+42.9%) |
Mar 1998 | - | $100.00 K(-75.0%) | $700.00 K(0.0%) |
Dec 1997 | $500.00 K(0.0%) | $400.00 K(+300.0%) | $700.00 K(+250.0%) |
Sept 1997 | - | $100.00 K(0.0%) | $200.00 K(-71.4%) |
June 1997 | - | $100.00 K(0.0%) | $700.00 K(0.0%) |
Mar 1997 | - | $100.00 K(-200.0%) | $700.00 K(0.0%) |
Dec 1996 | $500.00 K(+400.0%) | -$100.00 K(-116.7%) | $700.00 K(-12.5%) |
Sept 1996 | - | $600.00 K(+500.0%) | $800.00 K(+166.7%) |
June 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
Mar 1996 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
Dec 1995 | $100.00 K(0.0%) | - | - |
Sept 1995 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
June 1995 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
Mar 1995 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
Dec 1994 | $100.00 K(0.0%) | - | - |
Sept 1994 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
June 1994 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
Mar 1994 | - | $100.00 K(0.0%) | $300.00 K(0.0%) |
Dec 1993 | $100.00 K | - | - |
Sept 1993 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
June 1993 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
Mar 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is the all time high annual revenue for Theriva Biologics?
- What is the all time high quarterly revenue for Theriva Biologics?
- What is the all time high TTM revenue for Theriva Biologics?
What is the all time high annual revenue for Theriva Biologics?
Theriva Biologics all-time high annual revenue is $2.61 M
What is the all time high quarterly revenue for Theriva Biologics?
Theriva Biologics all-time high quarterly revenue is $2.19 M
What is the all time high TTM revenue for Theriva Biologics?
Theriva Biologics all-time high TTM revenue is $2.61 M